Industry Briefs

Tables Turn For Xerox Spin-Off Although Envos Corp., an artificial intelligence spin-off of the Xerox Corp., folded back into Xerox last spring after nine months in operation, the parent company is “absolutely” committed to developing similar ventures in the future, according to Xerox spokesman Peter Hawes. “We have been trying to identify [Xerox] technologies,” says Hawes, “and choose which. ..might lend themselves to alternative exploitation.” Envos, which

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although Envos Corp., an artificial intelligence spin-off of the Xerox Corp., folded back into Xerox last spring after nine months in operation, the parent company is “absolutely” committed to developing similar ventures in the future, according to Xerox spokesman Peter Hawes. “We have been trying to identify [Xerox] technologies,” says Hawes, “and choose which. ..might lend themselves to alternative exploitation.” Envos, which was85% owned by its employees, was one of approximately six Xerox spin-offs and joint ventures created since 1983. Envos’ product line consisted primarily of Lisp systems. Of its 22 professional employees, 13 were laid off; the remainder continue to work for Xerox, either as employees in other areas or as consultants.

Roger McKee, Envos’ former chief executive officer now working for the Xerox Connection, an internal unit based in El Segundo, Calif., says Envos’ problems began when the initial business plan was not accepted” by Xerox. “Xerox made ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies